日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Innovative liquid embolic agents based on deep eutectic solvent: Rapid gelation in situ via solvent exchange with water for endovascular embolization

基于低共熔溶剂的创新型液体栓塞剂：通过与水进行溶剂交换，在原位快速凝胶化，用于血管内栓塞

期刊:Bioactive Materials
影响因子:20.3
doi:10.1016/j.bioactmat.2025.02.037
Zhou, Yitong; Liu, Menghui; He, Chuandong; Lin, Jiayuan; Chen, Yanlv; Yu, Mingyu; Jiang, Yuhan; Peng, Xin
发表日期：2025
文献求助 收藏

Single epidural bolus hydromorphone for acute postpartum pain after vaginal delivery: a randomized clinical trial

单次硬膜外推注氢吗啡酮治疗阴道分娩后急性产后疼痛：一项随机临床试验

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-22232-7
Lu, Yixing; Wei, Wengui; Jiang, Wenqing; Liang, Qiumei; Jing, Shunzhong; Qin, Yanlv; Chi, Tao; Liu, Siyan; Lin, Yunan
发表日期：2025
文献求助 收藏

Unveiling heterogeneity and prognostic markers in ductal breast cancer through single-cell RNA-seq

通过单细胞 RNA 测序揭示导管乳腺癌的异质性和预后标志物

期刊:Cancer Cell International
影响因子:5.3
doi:10.1186/s12935-024-03325-1
Jianxun Hou #, Wei Liu #, Meihong Yan, Yanlv Ren, Cheng Qian, Yingqiang Fu, Hongbin Wang, Zhigao Li
肿瘤
乳腺癌
其它细胞
发表日期：2024
文献求助 收藏

Toremifene, an Alternative Adjuvant Endocrine Therapy, Is Better Than Tamoxifen in Breast Cancer Patients with CYP2D6*10 Mutant Genotypes

对于携带 CYP2D6*10 突变基因型的乳腺癌患者，托瑞米芬（一种替代辅助内分泌疗法）优于他莫昔芬。

期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2023.652
Li, Xin; Li, Zehao; Li, Lin; Liu, Tong; Qian, Cheng; Ren, Yanlv; Li, Zhigao; Chen, Kejin; Ji, Dongchen; Zhang, Ming; Wang, Jinsong
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

Age-related characteristics of sedation in pediatric patients and their correlated adverse events: a cohort study

儿童镇静的年龄相关特征及其相关不良事件：一项队列研究

期刊:Frontiers in Pediatrics
影响因子:2
doi:10.3389/fped.2024.1475891
Nong, Xiaoling; Lu, Yixing; Jiang, Wenqing; Qin, Yanlv; Jing, Shunzhong; Chi, Tao; Peng, Wei; Liu, Siyan; Lin, Yunan
发表日期：2024
文献求助 收藏

A Solvent Exchange Induced Robust Wet Adhesive Hydrogels to Treat Solid Tumor Through Synchronous Ethanol Ablation and Chemotherapy

溶剂交换诱导的坚固湿粘性水凝胶通过同步乙醇消融和化疗治疗实体肿瘤

期刊:Advanced Science
影响因子:
doi:10.1002/advs.202309760
Yanlv Chen, Meng Yu, Menghui Liu, Yang Sun, Chengxian Ling, Mingyu Yu, Wenwen Zhang, Wenkai Zhang, Xin Peng
肿瘤
发表日期：2024
文献求助 收藏

Over-expression of CDX2 alleviates breast cancer by up-regulating microRNA let-7b and inhibiting COL11A1 expression

CDX2 的过度表达通过上调 microRNA let-7b 和抑制 COL11A1 表达来缓解乳腺癌

期刊:Cancer Cell International
影响因子:5.3
doi:10.1186/s12935-019-1066-9
Hongbin Wang #, Yanlv Ren #, Cheng Qian, Jiaxin Liu, Ge Li, Zhigao Li
肿瘤
乳腺癌
ELISA
IP
WB
Human
HEY1
发表日期：2020
文献求助 收藏

Over-expression of FSIP1 promotes breast cancer progression and confers resistance to docetaxel via MRP1 stabilization

FSIP1 过度表达促进乳腺癌进展并通过 MRP1 稳定产生对多西他赛的耐药性

期刊:Cell Death & Disease
影响因子:8.1
doi:10.1038/s41419-018-1248-8
Meisi Yan, Jinsong Wang, Yanlv Ren, Lin Li, Weidan He, Ying Zhang, Tong Liu, Zhigao Li
肿瘤
乳腺癌
WB
Human
MRP1
发表日期：2019
文献求助 收藏

MiR-23a promotes TGF-β1-induced EMT and tumor metastasis in breast cancer cells by directly targeting CDH1 and activating Wnt/β-catenin signaling

miR-23a通过直接靶向CDH1并激活Wnt/β-catenin信号通路，促进TGF-β1诱导的乳腺癌细胞EMT和肿瘤转移。

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.18422
Ma, Fei; Li, Wenjie; Liu, Chunxiao; Li, Wei; Yu, Haining; Lei, Bo; Ren, Yanlv; Li, Zhigao; Pang, Da; Qian, Cheng
肿瘤
肿瘤免疫
TGF-β
信号转导
CDH1
Wnt/β-Catenin
乳腺癌
TGF-β1
细胞生物学
发表日期：2017
文献求助 收藏

Association of FGFR3 and FGFR4 gene polymorphisms with breast cancer in Chinese women of Heilongjiang province

黑龙江省中国女性FGFR3和FGFR4基因多态性与乳腺癌的相关性

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.5850
Jiang, Yongdong; Sun, Shanshan; Wei, Wei; Ren, Yanlv; Liu, Jing; Pang, Da
FGFR3
肿瘤
肿瘤免疫
FGFR4
乳腺癌
发表日期：2015
文献求助 收藏